Boulder, CO, 17 January 2023 – InDevR, Inc., a provider of best-in-class analytical technologies for vaccines and biotherapeutics, announced that it has raised $9 million in series B financing. Adjuvant ... Read More
InDevR will be presenting an Exhibitor Talk on November 7 at 12:50 - 1:00 pm ET. Speaker: April Blodgett To see our talk, visit the booth, and learn more about ... Read More
Past News and Events
GEN Webinar: Speed and Simplicity for mRNA Vaccines and Therapeutics CQA TestingRegister to view the webinarSpeaker: Kathy Rowlen, PhD Title: CEO & Co-founder InDevR Bio: Dr. Kathy Rowlen ... Read More
CHI Webinar – Aug 25th, 2022: Assessing neuraminidase presence in influenza vaccines using InDevR’s VaxArray PlatformRegister to view the webinarSpeaker: Jeff Pederson, Ph.D. Title: Global Head, Analytical Science ... Read More
InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization BOULDER, Colo., May 10, 2022 (Newswire.com) - InDevR, Inc., a life science tools company providing powerful analytical technologies to support the ... Read More
On-Demand WVC Webinar - May 10th, 2022: New CQA Test Kits for Multivalent Influenza Vaccines: 1 Hour Assay Provides Multiplexed Identity, Quantity, and Stability Testing We Invite you to our ... Read More
World Vaccine Congress - April 18-21 2022 InDevR will be exhibiting and giving a short talk at the World Vaccine Congress. Talk Title: Identity, Quantity, and Integrity Characterization of Multivalent ... Read More
World Antiviral Congress - November 30 to December 2, 2021 InDevR will be exhibiting and giving a short talk at the World Antiviral Congress. The talk is titled " Customer ... Read More
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.